steve kirsch fluvoxamine
including the very promising Fluvoxamine. Dosing. But fear of trying something new prevents any doctor from giving this drug a try. If you continue to get this message, Skirsch.io traffic volume is 1,957 unique daily visitors and their 3,914 pageviews. . It was tested in coronavirus patients because fluvoxamine has very strong anti-inflammatory properties. The NIH wrote a bullshit rejection because the FDA told them not to approve it. Molnupiravir followed patients for only 30 days because they know the drug is dangerous. Steve and CETF funded the research that showed promising results of fluvoxamine as an early treatment of COVID-19. Why the FDA should grant an EUA for fluvoxamine immediately, Links to evidence about fluvoxamine including the public data repository, Here's the first one: . Steve Kirsch, current director of the Covid 19 Early Treatment fund is an MIT alumni who has made a career as a tech entrepreneur. Steve Kirsch was extremely helpful early on in the pandemic, stepping up to fund early treatment trials when the US government would not fund such studies, Boulware told me in an email. One of the first CETF grants was to investigate the antimalarial hydroxychloroquine. In two trials (both published studies in peer reviewed journals with Editor's Choice in both cases), the drug had a 100% effect size in protecting against hospitalization from the respiratory symptoms from COVID. Be warned!. I bumped up the reward to $1M. Fluvoxamine public data repository - Google Drive, On Cytokines, Fluvoxamine and COVID-19 Part 1, Jon-Emile S. Kenny MD[@heart_lung] You see, we have a kind of allergy to the past; its our national disease, and the very assurance with which you insist that the past is within the present is l, On Cytokines, Fluvoxamine and COVID-19 Part 2, Jon-Emile S. Kenny MD[@heart_lung] Apocalypse is played out now on a personal scale; it is not in the sky above us, but in our bed. -Mark Doty Introduction With a proposed pathway coupling patho, Effect of Fluvoxamine vs Placebo on Clinical Deterioration in Outpatients With Symptomatic COVID-19, This randomized trial compares the effects of fluvoxamine, a selective serotonin reuptake inhibitor with immunomodulatory effects vs placebo on a composite of dyspnea or pneumonia and oxygen desaturation among adult outpatients with polymerase chain reactionconfirmed mild coronavirus disease 2019 (, Prospective cohort of fluvoxamine for early treatment of COVID-19, Abstract. The group who declined the drug were very sick with 12.5% requiring hospitalization and one died. Physicians who use the drug for COVID now swear by it. . [https://www.quora.com/What-is-the-current-treatment-for-Covid-19/answer/, The most urgent need in the country right now is to reduce. Steve wanted to say, Look, Ive got all these famous [infectious disease] docs and researchers, and they all say give fluvoxamine a chance, Judith Feinberg, one of the former CETF advisory board members and vice chair of research at the West Virginia University School of Medicine, told me. There were no studies reported out so far where fluvoxamine made things worse or neutral. What's even worse is that a third of recovered patients from COVID will return to the hospital within 5 months and 1 in 8 die. I am not aware of a single case where taking the made things worse, e.g., person was doing fine BEFORE the drug and symptoms worsened after taking the drug. Their willingness to lie did. The collateral damage is that, now, a lot of people dont trust scientific leaders or the scientific community. The combined p value of the two studies is <.0001. It does not matter how many lives will be saved. This site requires JavaScript to run correctly. We pretty much practice government agency opinion medicine all over the world now, with just a few exceptions. The US government accused Janssen of improperly promoting the antipsychotic drug Risperdal to dementia patients despite the drug increasing deaths in the elderly. Part of TV News Archive. The most stunning study of fluvoxamine ever done was at the Golden Gate Fields racetrack in November 2020, right after the WashU trial was published in JAMA. It used to be that a Phase 3 study would do it. Food/drugs to avoid while on fluvoxamine. They rejected the drug for insufficient evidence just like they always do for ivermectin. Boulwares trial was part of a wider movement to bulk up the evidence base underlying standard covid treatments, and one of several trials that found no benefit to using hydroxychloroquine. All have had a 100% success record in keeping their patients out of the hospital. Completely avoid caffeine, alcohol, tylenol, and benadryl. Hes refused to accept the results of a hydroxychloroquine trial that showed the drug had no value in treating covid, for instance, instead blaming investigators for poor study design and statistical errors. While YouTube has repeatedly taken down the full video of the DarkHorse episode, various clips have been watched over 4 million times, and the full audio remains available on Spotify. An MIT Technology Review investigation recently revealed how images of a minor and a tester on the toilet ended up on social media. We should not wait for the Phase 3 RCT. But an Editor's Note urged physicians to treat this as a hypothesis and not as a basis for clinical decision-making. But they will refuse to give it to you even after being proven in a Phase 3 trial that was approved by the WHO. He immediately tweeted an offer to give anyone $1 million if they could win a debate with him about vaccine deaths. We dont want to feed the anti-vaccine trolls, so we actively suppress clear scientific data. A very short op-ed arguing for using fluvoxamine against COVID. If there is a better drug on the table today than fluvoxamine, the NIH panel should put that one on the guidelines. In some cases, youd want to taper down the dosage. This is quite stunning because the PK of the drug done at the Gates Foundation shows it only reaches 50% of the final concentration after 3 days. Links to evidence about fluvoxamine including the public data repository. Ive talked to doctors who are extremely familiar with the drug and all the trial results and they would prescribe it to their patients. Seftel used a 50mg BID dosing for 14 days which was one third of the max dose used in the Lenze study. Mouse Systems is not a household word, he told the journalist. Here is what, e) which concluded: Under a variety of assumptions, fluvoxamine shows a high probability of preventing hospitalization in outpatients with COVID-19., For more about fluvoxamine (and other SSRIs that work), see, fluvoxamine completed a Phase 3 study showing it works that was published in the Lancet Global Health, NIH basically dismissed the fluvoxamine study as I predicted they would, few people werent afraid of expressing their displeasure, the highly acclaimed Bangladesh mask study showed, Johns Hopkins has incorporated fluvoxamine in their treatment guidelines, Ontario has become the first province to list fluvoxamine as a treatment doctors can consider for patients. Although there is evidence that fluvoxamine can prevent clinical worsening and the need for hospitalizations in outpatients with early covid-19, I have seen no good evidence that fluvoxamine is useful as a substitute for the vaccines, co-investigator Angela Reiersen wrote to me. We could have saved a lot of lives. Author Affiliations . Added to FLCCC protocols and Fareed-Tyson protocol among others. The track management was so impressed, they asked for prescriptions. Some countries dont have fluvoxamine so this is the alternative. Immediately after the results of the first fluvoxamine trial were releasedbut before they were published in a peer-reviewed journalhe wrote a post on Medium.com called The Fast, Easy, Safe, Simple, Low-Cost Solution to COVID That Works 100% of the Time That Nobody Wants to Talk About.. All the medical journals refused to publish the meeting notes (rejected by 6 journals). But they will refuse to give it to you even after being proven in a Phase 3 trial that was approved by the WHO. The Wall Street Journal thinks it should be used (and that the NIH is wrong for waiting for more clinical trials). Completely avoid caffeine, alcohol, tylenol, and benadryl. Most recent articles first. Steve Kirsch: Vaccine Killing Millions, Treatments, VAERS, 5-Month Death Signal, Mystery Clots Embed 7.76K 31 'This Has Cost Millions Of Lives': Steve Kirsch On Suppression Of Repurposed Drugs And A Spike In Deaths 5 Months After Vaccine Rollout By Jan Jekielek American Thought Leaders / The Epoch Times November 24, 2022 Show more He started a new pseudonymous account, @VaccineTruth2, to continue broadcasting messages. Doing something is better than nothing. But even she was drained by Kirschs constant attempts to override the data. Doctors who have used fluvoxamine in the US and other countries swear by it. He says that Facebook took down one of his posts announcing his appearance on 60 Minutes. If the drug is started right after symptoms, weve seen 100% prevention in hospitalization. This drug can save your life but you have to ask for it! There are reports of people who cant tolerate the drug, but they stop using it and nothing bad happened. Reached by email, the two fluvoxamine investigators denied that there was any effort to suppress their research, and they were cautiously optimistic about their continued study. After publication of the recommendation in December 2021, the NIH did absolutely nothing change their recommendation. Kirsch, despite having direct access to the actual trial runner, eventually became convinced a correct interpretation of the data would show that hydroxychloroquine worked. Worst case, if we ignore all additional evidence so the average is a 60% pass rate. Repurposed drugs are safer and more effective than the current vaccines. Last Checked: 03/02/2023. Compulsive fiddling with your mask? That work has yielded one promising candidate, the antidepressant fluvoxamine; other CETF-funded efforts have been less successful. Mr. Steve Kirsch - A philanthropist and former Silicon Valley tech executive. Hes a genuinely good guy. If you cant lay off the java, then try fluoxetine (Prozac). A few months ago, Kirsch suddenly stopped promoting hydroxychloroquineeven scrubbing it from the CETFs official list of trials it has funded. Proxalutamide and fluvoxamine pushers and the early treatment grift. Kirsch and his group received a fresh wave of attention off hopeful trials of the antidepressant fluvoxamine, which ultimately won him a spot on 60 Minutes in March. My crime? For decades, coders wrote critical systems in C and C++. . Online. The sooner you start, the better the outcomes. If you have trouble getting a prescription, perhaps you have OCD? I took it myself at that dosage and noticed zero side effects. Saving the world has been a theme of Kirschs life for years. It is an amazing drug and is a very simple safe way to avoid long-haul COVID symptoms. On his blog, Covid-19 Data Science, he has extensivelyand mercilesslyunpacked Kirschs evidence for the vaccine death claims. - Quora, Heres presentation I gave at the re-open California Conference on January 9,2021: How to fix the problemHow to fix the problem Steve Kirsch Executive DirectorCOVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008Google Docs[https://docs.google.com/presentation/d/1-A4y78wv3tTPmVu57FOabY6j-MJbPwMGojKwZfaCkAs/. The most stunning study of fluvoxamine ever done was at the Golden Gate Fields racetrack in November 2020, right after the WashU trial was published in JAMA. So when a group of scientists applied for an EUA for fluvoxamine, what did the FDA do? Here is the latest version. The differences are obvious to untrained eyes. and here are the slides I used in, Collections of op-eds and presentations about fluvoxamine, Please see my answer on Quora Other drugs in this class include Prozac (fluoxetine), Zoloft (sertraline) and Paxil (paroxetine). The NIH wrote a bullshit rejection because the FDA told them not to approve it. Fluvoxamine, COVID, pandemic, . There are 4 outpatient studies that have been done (2 at WashU (see Phase 2 trial results published in JAMA), one in Berkeley, CA by David Seftel, one in Brazil published in the Lancet, and one in-patient study done in Croatia. In severe cases, it takes longer. Note that a total of 77 people got the drug, not 65. ALWAYS check with your doctor and report any medications you are taking before or plan to take after you start taking fluvoxamine. They left their recommendation of fluvoxamine at NEUTRAL. Medicine has been transformed to doing whatever the NIH/FDA says, regardless of how many lives will be lost. If you are experiencing any odd adverse reactions, youll need to consult with your doctor ASAP. I fully expected both organizations to do absolutely nothing. 19 In addition, several . Kirsch is a serial entrepreneur who has spent decades pitching the next big thing, whether optical mice (Mouse Systems), document processing (FrameMaker), search engines (Infoseek), digital. 95% confidence effect size is 75% or more. I learned this the hard way. thinks it should be used (and that the NIH is wrong for waiting for more clinical trials). this is NOT about the science. Steve Kirsch -Executive Director at COVID-19 Early Treatment Fund Ivermection study - One .2mg/kg dose a week for prevention "100% success rate whereas those doctors taking placebo had a 59%% infection rate not a typo 237 of 400 docs on placebo got infected vs. 800 docs on Ivermectin none got infected" Antivirals Ive used it personally at 50mg twice a day and experience no adverse events at all. Almost 2.5 million people signed up to Dr. B with the promise of getting leftover vaccines. Drug interactions should be checked for. No long haul symptoms if you start the drug ASAP after first symptoms. In the second trial, it was shown to be 100% effective in long-haul COVID symptoms: None of the treated patients had any long-haul symptoms after 2 weeks compared to 60% of untreated patients having 1 or more of the 15 long-haul symptoms after two weeks, and 29% having 4 of more of the long haul symptoms after 2 weeks. Note: normally I have lots of hyperlinks to all the sources, but Im pressed for time. They all promised me when fluvoxamine passed Phase 3 trials, nearly everyone would use it. Kirsch is a serial entrepreneur who has spent decades pitching the next big thing, whether optical mice (Mouse Systems), document processing (FrameMaker), search engines (Infoseek), digital. He retired at the largest pension in federal history. It is about following orders and making money for the drug companies and protecting the doctor from liability and losing his medical license. Thats why they didnt even fund the fluvoxamine trial, he told me. Think about it Molnupiravir has a 50% risk reduction whereas fluvxoamine is over 90%. My website www.skirsch.io has tons of info on fluvoxamine with all the links. He has a history of giving away some of his millions to good causes, and when COVID-19 began. Several other trials around the world are in the final stages, too. . After two weeks (since it was a tight knit community, everyone could see what was happening to the two groups), every track worker who got sick with COVID, demanded the drug. Is that really true? So check the side-effects list to be familiar with which side-effects are associated with which drug so if you have a side-effect, youll know which drug to reduce or eliminate. The claim that the spike is toxic, that came directly from the [DarkHorse episode]. This advice is now outdated. Consider masks by contrast. The reason that it isnt used is because the medical community ignores evidence-based medicine principles. So instead of this paper being treated as confirming an earlier hypothesis, it was treated as generating a novel hypothesis. After two weeks (since it was a tight knit community, everyone could see what was happening to the two groups), every track worker who got sick with COVID, demanded the drug. There were IRB rules that required the 65 patients to be listed in the diagrams and charts. Download Citation | On Mar 1, 2023, Gne Seda Albayrak and others published A Cross-Sectional Study on the Personality Traits of Episodic and Chronic Migraine Patients | Find, read and cite all . Im not going to make the same mistake again.. Design thinking was supposed to fix the world. This is the gold standard of evidence based medicine. So take the lowest likely effect size * 60% success rate and you are looking at an expected 45% reduction in death which is clearly better than a 0% reduction. A very short op-ed arguing for using fluvoxamine against COVID. 47).. Steve Kirsch is a high-tech serial entrepreneur based in Silicon Valley. All the supporting observational studies were positive as well. Yes, these were successes, but the successes could have been bigger if we had really paid attention to marketing. CETF Founder Steve Kirsch discusses why we can't wait for a COVID-19 vaccine, the importance of researching existing drugs now, and our work to raise funds for outpatient trials to identify effective . It was 25 years ago yesterday that Andrew Wakefield launched the modern iteration of the antivaccine movement.In doing so, he laid down a template that antivax quacks today still follow. We don't know why the NIH panel is ignoring fluvoxamine and we aren't allowed to find out. Medium revoked my account for life. While Fauci was crafting national pandemic policies, Fauci's wife [Christine Grady, Chief Bioethicist, NIH] was back stopping [them]." Report coming soon. But Kirsch is also motivated by an unsatisfied competitive streak. Kirsch: Yes, but you could easily watch that 60 Minutes story and believe that we need more data before people should start using fluvoxamine. 533. Steve Kirsch is an inventor of the optimal mouse, a Silicon Valley millionaire, and an MIT alum (Class of '80). The 5 observational studies is icing on the cake. You can use fluoxetine as well (aka Prozac). How can we get fluvoxamine? He has been a medical philanthropist for more than 20 years. In 2013, Johnson & Johnson paid $2.2 billion for its own kickback and fraud scandal, including a specific $400 million fine for its subsidiary Janssen, which manufactures the covid vaccine. I think we did rigorous reviews of proposals for research.. Boulware disputes that, and says that although Kirschs funding was important, his statements about drugs and vaccines have proven problematic. To protect M10 from my COVID-19 vaccination opinions, I will no longer post about my vaccination concerns here.. We could have saved a lot of lives. If you do have a side-effect, it is usually mild nausea which goes away when you stop taking the drug. This is what the Seftel trial at Golden Gate fields used. By Steve Kirsch Mar 14, 2021 Fluvoxamine, Proxalutamide, and Ivermectin: 100% success I'm very bullish on two drug combos since it is rare for a single drug to be 100% successful. We now have a viable solution to reduce COVID hospitalization and mortality; Say you just got diagnosed with COVID. Try refreshing this page and updating them one 1991-1992 to 7.1% in 2001-2002. So far, doctors have failed to share his sense of urgency. The effect size is huge if the drug is given early right after symptoms start. I agreed to do it partially because I respect Bob [Siliciano] so much, and partially because I thought the concept was excellent, said former board member Doug Richman, a prominent HIV drug researcher at the University of California San Diego and former member of the funds scientific advisory board. None of this would really matter if Kirschs views on vaccinations were private, or shared with a limited audience. Nov 12: Steve Kirsch gives talk on CETF to HarvardBusiness School hosted by Dr. Seftel Nov 13:Mass COVID outbreak at GGF is now publiclyknown Nov 16: Seftel, the track physician at GGF, startsFLV . And, according to three members of CETF's scientific advisory board, he put pressure on them to promote fluvoxamine for clinical use without conclusive data that it worked for . CETF funded David Boulware's trials on hydroxychloroquine and the Phase 2 and Phase 3 fluvoxamine trials, among many other research projects. Flavio Cadegiani and Steve Kirsch's studies didn't make the cut. But a panel of key opinion leaders from the NIH, CDC . Fluvoxamine for COVID-19 summary Steve Kirsch Executive Director COVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008 Google Docs This is a more comprehensive look at the key evidence supporting fluvoxamine: Fluvoxamine for COVID-19 How I recommend people treat COVID and the fascinating backstory of how fluvoxamine was discovered. It has shown to be 100% protective of hospitalization in 2 clinical trials. Who knows, Morris replied. Generally, at 50mg BID x 14, it is very tolerable as long as the patient is instructed to lay off the caffeine. Zero. Steve Kirsch is baffled. After I ended the Zoom meeting, Satterfield called me to apologize for cutting us off. Thirty minutes past the end of our scheduled time, he dropped his phone in the cupholder of his Tesla so that he could keep talking while he ran an errand. Personal life. It's hard to ignore this lecture in explaining why the drug is so effective. Enter the email address you signed up with and we'll email you a reset link. Please. skirsch.io. Thats pretty typical, but your mileage may vary. Elsewhere he has said he began questioning vaccine safety after an unnamed Twitter follower told him several family members died after getting their shots. Always be self aware when using fluvoxamine. It was tested in. One Silicon Valley entrepreneur thought he could beat the odds. They never make things worse so are safe to try. We don't know why the NIH panel is ignoring fluvoxamine and we aren't allowed to find out. . After publication of the recommendation in December 2021, the NIH did absolutely nothing change their recommendation. Our in-depth reporting reveals whats going on now to prepare you for whats coming next. Some people are jittery, but usually that is because the doctor either prescribed a dosage higher than 50mg twice a day or didnt notify the patient to. Steve Kirsch Executive Director at COVID-19 Early Treatment Fund (2020-present) Author has 176 answers and 1.7M answer views Updated 1 y Both. Sadly, doctors and public health officials refuse to instruct patients to seek early treatment. Steve Kirsch cut the check, which allowed Dr. Lenze to finish recruiting the 152 patients he needed for his trial. Fluvoxamine works on hospitalized patients too, but no US hospital will let you use it (sound familiar? They immediately ruled out the vaccine, because the vaccine is, quote, safe.. Proven in clinical use all over the world. Then he hosted a superspreader event. (The ivermectin data are trash, Feinberg told me. My favorite dosage is 50mg twice a day for 14 days. [4] Steve Kirsch - Silicon Valley Philanthropist Shares Review of CDC Data: COVID-19 Vaccine Associated with 100X Deaths Compared to Influenzas [5] Steve Kirsch - FOIA Document for Vaccine Discussion as to mRNA-based Vaccine Safety Signals Added 12th August 2021: Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI), a class of anti-depressants, mostly prescribed for people suffering from an obsessive-compulsive disorder. But how many did it help? Fluvoxamine is also an You will be wired for 24 hours if you dont heed my advice. So why would we wait when lives are being lost? On January 22, 2021, thirty key opinion leaders (KOL) from NIH, CDC, and leading academic institutions met to review the evidence for using fluvoxamine for treating COVID. By the beginning of September, he was no longer the companys CEO, replaced by his co-founder, Marten Nelson. He's discovered a common medication that's highly effective in minimizing the impacts of COVID-19 - two studies have proven so. Seftel was able to duplicate the 100% protection from hospitalization and death in the treatment group, vs. a 12.5% hospitalization/death rate for the No treatment group. Or just depression about the vaccine mandates? Weve known it works since August 24, 2020. Here are my answers. . At the dosing for COVID (50mg BID x 14 days), there is a 1% chance of mild-nausea and because the dose is so low and the time it is taken is so short, and there are no psychotropic effects (which require more than 3 weeks of use; the psychotropic effects non-existent if you don't have depression or an anxiety disorder in the first place). Substitutions. (article I did after the TOGETHER trial). Another is to identify an asteroid that is going to hit the planet.. Eventually, a press representative who was listening in, David Satterfield, unmuted his microphone to suggest we finish our conversation by email. That receptor also helps regulate the body's . committee votes 11-2 that the evidence is not adequate to demonstrate a net health benefit for molnupiravir over symptomatic care alone; Paxlovid and fluvoxamine receive more favorable votes, This site requires JavaScript to run correctly. And not zero., Kirsch immediately forwarded the exchange to me and, I suspect, other journalists. Fluvoxamine is way better than Molnupiravir, but the NIH doesnt approve drugs on effectiveness. So probability of successful Phase 3 can be estimated to be over 99.99% since there are tens of thousands of phase 3 studies. . At the beginning of the COVID-19 pandemic, Steve Kirsch created the COVID-19 Early Treatment Fund (CETF) to finance trials of off-patent drugs in an attempt to find a potent treatment that had been staring us in the face. But while this effort was praiseworthy, Kirsch's predilection for oversimplifying and exaggerating led him to mislead. While combining the results of several well-designed trials can strengthen an argument or unearth patterns unseen in smaller samples, a meta-analysis is just the sum of its parts; any single well-done experiment is more useful than combining the results of several poorly done ones. It could do nothing. But the confusion provided a fertile breeding ground for skeptics. A video presentation by Steve Kirsch, Executive Director of the Covid-19 Early Treatment Fund. MD, MPH; Steven C. Marcus, PhD. The WashU Phase 3 study hasnt been disclosed yet, but they had compliance problems with their patients this time around (phase 2 was local so the patients got the drug early and also were very compliant and the placebo group was truly taking nothing). The documents in the data room discuss all eight (you'll need access to the restricted area to see the presentation on all 8). The NIH picks the drug that makes the most money for the drug companies regardless of long-term safety Molnupiravir! Hes very convincing. Hes probably the closest thing Kirsch has to a nemesis, regularly disputing his assertions in blog posts and private email exchanges with Kirsch and his friends. But as Kirsch has clashed with the experts he initially surrounded himself with, hes grown increasingly close to others who share his perspectives on vaccineswho have, in turn, provided a large and receptive audience to his claims about a fluvoxamine conspiracy. Steve Kirsch said scientists and clinicians are studying a host of drugs and therapeutics to create a new line of defence against the virus but clinical trials are yet to lead to conclusive. I've collected fluvoxamine evidence here for convenient access. This give another 50% of benefit. How can the FDA say a drug which meets the gold standard of evidence has insufficient evidence? The choice couldn't be more clear cut. It never was. Ivermectin and fluvoxamine have been confirmed in Phase 3 trials. There are now 5 independent observational studies that show that the drug works (2 in France, 1 in Germany, 2 in the US). For example all of these combos should have near 100% success against hospitalization, death, and long-haul COVID symptoms: Proxalutamide and fluvoxamine JAMA systematic review and meta analysis It doesnt get any better than this. Its board told him that if he wanted to remain part of the company he would have to stop making public anti-vaccine statements. He prefers iconoclastic approaches, whether by directly funding asteroid detection or advocating for nuclear power to combat global warming. The Lancet paper showed that if you were treated early enough and took the drug as prescribed (it only works if you take it), it was shown to reduce your chance of death by 12X making it far more effective than any other drug for COVID. Dose escalation studies in lupus patients and in rheumatoid arthritis patients established that 800 mg per day for life and 1,200 mg per day for 6 weeks are extremely well-tolerated. . Hes now outlived his initial prognosis by several years. Why not fluvoxamine? Discover special offers, top stories, Other SSRIs work as well, but fluvoxamine activates the Sigma-1 receptor the most of the SSRIs which is why it was chosen. If you wanna find someone to debate me for ten thousand dollars, or a thousand dollars, Im happy to do that, just for your benefit.. of the 'intellectual dark web '" and allowed him to access a "large and receptive audience to his claims about a fluvoxamine conspiracy". The drugs mechanisms of action were explained to the KOL panel which voted 2>1 in favor of fluvoxamine. Fluvoxamine has a systematic review and meta-analysis published in a top medical journal.